Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.37 HKD
352.87 M HKD
1.20 B HKD
207.69 M
About ORBUSNEICH MEDICAL GRP HLDGS LTD
Sector
Industry
CEO
David Chien
Headquarters
Hong Kong
FIGI
BBG01BYJG034
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The firm through its subsidiaries engages in the manufacturing, trading, sales and marketing of medical devices & instruments used for the treatment of coronary and peripheral vascular diseases. The company was founded on July 22, 2021 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6929 is 4.03 HKD — it has decreased by −1.42% in the past 24 hours. Watch ORBUSNEICH MEDICAL GRP HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ORBUSNEICH MEDICAL GRP HLDGS LTD stocks are traded under the ticker 6929.
6929 stock has risen by 2.72% compared to the previous week, the month change is a 5.05% rise, over the last year ORBUSNEICH MEDICAL GRP HLDGS LTD has showed a −34.89% decrease.
6929 reached its all-time high on Mar 14, 2023 with the price of 16.86 HKD, and its all-time low was 2.86 HKD and was reached on Aug 5, 2024. View more price dynamics on 6929 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6929 stock is 3.23% volatile and has beta coefficient of 0.73. Track ORBUSNEICH MEDICAL GRP HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is ORBUSNEICH MEDICAL GRP HLDGS LTD there?
Yes, you can track ORBUSNEICH MEDICAL GRP HLDGS LTD financials in yearly and quarterly reports right on TradingView.
ORBUSNEICH MEDICAL GRP HLDGS LTD is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
6929 net income for the last half-year is 147.22 M HKD, while the previous report showed 155.53 M HKD of net income which accounts for −5.34% change. Track more ORBUSNEICH MEDICAL GRP HLDGS LTD financial stats to get the full picture.
ORBUSNEICH MEDICAL GRP HLDGS LTD dividend yield was 1.42% in 2023, and payout ratio reached 23.46%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 1.25 K employees. See our rating of the largest employees — is ORBUSNEICH MEDICAL GRP HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORBUSNEICH MEDICAL GRP HLDGS LTD EBITDA is 284.79 M HKD, and current EBITDA margin is 26.93%. See more stats in ORBUSNEICH MEDICAL GRP HLDGS LTD financial statements.
Like other stocks, 6929 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORBUSNEICH MEDICAL GRP HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORBUSNEICH MEDICAL GRP HLDGS LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORBUSNEICH MEDICAL GRP HLDGS LTD stock shows the neutral signal. See more of ORBUSNEICH MEDICAL GRP HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.